Trial description:
Short-course radiotherapy plus olaparib for newly diagnosed glioblastoma in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose escalation study
Contact name:
Dr Sarah Jefferies
Trial start date:
Friday, November 4, 2016
Trial end date:
Thursday, April 30, 2020
Trial tumour type:
Brain and CNS
Show on Radiotherapy:
Yes
